Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Edgewise Therapeutics Inc.
EWTX | US
31.58
USD0.35
1.12%
EWTX | US
Loading StockChartView...
About Edgewise Therapeutics Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
31.58
Open
31.40
High
32.03
Low
30.93
Edgewise Therapeutics Inc. a biopharmaceutical company discovers develops and commercializes therapies for the treatment of muscle disorders. Its lead product candidate EDG-5506 an orally administered small molecule that is in Phase II clinical trials designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company also develops EDG-7500 a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders. In addition it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The Company was incorporated in 2017 and is headquartered in Boulder Colorado.
View LessEWTX | US
Risk
42.6
Sharpe
1.54
Luna's Score
63/100
Recommendation
Hold
Luna says (EWTX | US)
What's Working
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
41.6%1 month
42.6%3 months
44.1%6 months
81.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
6.52
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-2.60
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-134.29M
MarketCap
2.96B
MarketCap(USD)
2.96B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-28.20
Short ratio
5.47
Short perc.
14.62
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
4.07
Range1M
5.29
Range3M
8.18
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.22
Price X volume
29.28M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.60 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 6.52 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 44.09 | 72.80 | Lower Risk |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 2.96B | 3.66B | Par |
